SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-026574
Filing Date
2020-05-21
Accepted
2020-05-21 16:47:09
Documents
5
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q xene-10q_20200331.htm 10-Q 1687992
2 EX-31.1 xene-ex311_8.htm EX-31.1 18866
3 EX-31.2 xene-ex312_7.htm EX-31.2 18929
4 EX-32.1 xene-ex321_6.htm EX-32.1 11554
5 EX-32.2 xene-ex322_9.htm EX-32.2 11191
  Complete submission text file 0001564590-20-026574.txt   1749517
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36687 | Film No.: 20902478
SIC: 2834 Pharmaceutical Preparations